SCHEMBL7267768

SCHEMBL7267768

COCCNc1nc(-c2ccc(Cl)cc2)nc2cc(OC)c(OC)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
CYP1A2 P05177 8/20 0.54
CYP3A4 P08684 8/20 0.54
CYP2C19 P33261 5/20 0.54
CYP2D6 P10635 4/20 0.54
ALOX15 P16050 4/20 0.54
TSHR P16473 4/20 0.54
HTT P42858 1/20 0.52
ALDH1A1 P00352 6/20 0.52
HSD17B10 Q99714 3/20 0.52
TP53 P04637 3/20 0.52
MAPT P10636 3/20 0.52
KDM4E B2RXH2 3/20 0.52
LMNA P02545 3/20 0.52
HPGD P15428 1/20 0.52
HBB P68871 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
USP2 O75604 4/20 0.51
TLR9 Q9NR96 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7262644 0.93 MEN1 (0.71) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7262660 0.88 HTT (0.68) MEN1KMT2AHTTALDH1A1TP53
SCHEMBL7261431 0.88 HTT (0.56) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7262687 0.86 MEN1 (0.65) MEN1KMT2AHTTALDH1A1TP53
SCHEMBL7266347 0.84 MEN1 (0.53) MEN1KMT2ACYP1A2CYP3A4CYP2C19
Hydrochloric Acid SCHEMBL7266371 0.83 POLB (0.47) MEN1KMT2AHTTALDH1A1TP53
SCHEMBL7266405 0.83 MEN1 (0.56) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7262033 0.82 KMT2A (0.54) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7268568 0.82 PDE10A (0.55) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL7267747 0.81 PDE10A (0.65) MEN1KMT2ATSHRHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 WO disclosed